CONTROL OF HIV-ASSOCIATED TUBERCULOSIS IN THE KAZAKHSTAN REPUBLIC
https://doi.org/10.21292/2075-1230-2017-95-11-43-48
Abstract
Due to the efforts of TB services and state support, the threat of tuberculosis has diminished compared to the past, but for its drug resistant forms. InKazakhstan, the stable annual growth of HIV incidence is concerning. Under these circumstances, TB/HIV co-infection becomes a crucial issue as well as its control.
The objective is to evaluate the epidemic situation and tactics of TB/HIV co-infection control in the Kazakhstan Republic (KR).
Subjects and methods. The retrospective epidemiological analysis was performed based on the KR National Register of Tuberculosis Patients for 2010-2015. The KR regulations were studied in order to analyze the organization of anti-tuberculosis care for TB/HIV.
Conclusions. The increase of tuberculosis cases among people living with HIV is due to growing notification of new cases, and every third case is caused by drug resistant strains. Unfortunately, despite the fact that all tuberculosis cases, including resistant ones can be cured and they are not that dangerous as in the past, but for people living with HIV, TB remains to be the major concurrent disease and one of the main causes of death. The strategy of integrated tuberculosis control implemented currently inKazakhstan requires new organizational and financial decisions in the health care organisation of the Republic.
About the Author
E. A. AlikeevaKazakhstan
Elmira A. Alikeeva – Kazakhstan National Research Center of Phthisiopulmonology, Doctor of Department of Epidemiology, Monitoring, Evaluation and Strategic Planning.
5, Bekkhozhina St., Almaty, 050010
References
1. Berikova E.А. et al. Main aspects of MDR/XDR TB in Kazakhstan. Phthisiopulmonology, no. 2, 2016, pp. 14-15. (In Russ.)
2. WHO Information Bulletin. no. 94, 2016, http://www.who.int/mediacentre/factsheets/fs104/ru/ (In Russ.)
3. Ismailov Zh.K., Berikova E.А. et al. Rukovodstvo po integrirovannomu kontrolyu tuberkuleza. [Guideline on integrated tuberculosis control]. Eds. Duseynova T.K. Almaty, 2016, pp. 204-2011.
4. Lepshina S.M. Three vectors of current epidemics of tuberculosis. Ukr. Pulmonologichesky J., 2008, no. 3, pp. 21-22. (In Russ.)
5. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. WHO Guideline, 2015 http://www.rcaids.kz/files/00002884.pdf (In Russ.)
6. Edict no. 1079 as of December 30, 2015 On Certain Issues of Prevention of Co-infection. (In Russ.)
7. AIDS Epidemic Update: December 2002, UNAIDS, 2002, http://www.who.int/hiv/facts/en/epiupdate_ru.pdf (In Russ.)
8. WHO Three I’s Meeting Report. Intensified Case Finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV. Geneva, Switzerland,WHO,2008http://www.who.int/hiv/pub/tb/3is_mreport/en/
Review
For citations:
Alikeeva E.A. CONTROL OF HIV-ASSOCIATED TUBERCULOSIS IN THE KAZAKHSTAN REPUBLIC. Tuberculosis and Lung Diseases. 2017;95(11):43-48. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-11-43-48